Nike
NKE
$42.62
-3.14%
Nike, Inc. is the world's largest athletic footwear and apparel brand, operating in the Consumer Cyclical sector within the Apparel - Footwear & Accessories industry. The company is a dominant market leader and brand powerhouse, distinguished by its portfolio of iconic brands including Nike, Jordan, and Converse, and its extensive global distribution network spanning owned retail, wholesale, and e-commerce. The current investor narrative is intensely focused on the viability and timeline of a corporate turnaround, as recent earnings reports and guidance have highlighted significant headwinds in China, margin pressures, and a slower-than-expected recovery, leading to a sharp debate over whether the stock's multi-year lows represent a value opportunity or a value trap.…
NKE
Nike
$42.62
Related headlines
Investment Opinion: Should I buy NKE Today?
Rating: Hold. The core thesis is that while NKE's brand and balance sheet provide a long-term floor, near-term fundamental deterioration and a still-rich valuation create significant headwinds that preclude a Buy rating until clearer signs of a turnaround emerge.
Supporting evidence includes a forward P/E of 22.1x, which implies an earnings recovery that is not yet visible in the flat YoY revenue and collapsing margins. The stock trades just 0.6% above its 52-week low, suggesting limited immediate downside but also reflecting profound negativity. Analyst revenue estimates for the period average $58.27B, indicating expectations for modest growth, but the wide 7% range between high and low estimates underscores high uncertainty. The healthy current ratio of 2.21 and ROE of 24.36% are positive, but they are defensive attributes, not catalysts for upside.
The thesis would upgrade to a Buy if the forward P/E compresses below 18x (aligning more with a no-growth scenario) alongside evidence of sequential gross margin stabilization above 41%. It would downgrade to a Sell if revenue growth turns negative YoY or if the stock breaks below its 52-week low of $42.36 on high volume, signaling a new leg down. Relative to its own history, the stock is fairly valued at the lower end of its P/E range, but relative to its current near-zero growth profile, it remains overvalued, requiring proof of a recovery to justify its multiple.
Sign up to view all
NKE 12-Month Price Forecast
The assessment is neutral with medium confidence. The severe technical oversold condition and strong balance sheet provide a tangible floor, but they are offset by deteriorating fundamentals and a valuation that still implies a recovery. The most likely path is the base case of a slow, grinding stabilization. The stance would upgrade to bullish on evidence of two consecutive quarters of sequential gross margin improvement and China sales stabilization. It would turn bearish on a confirmed break below $42 with deteriorating volume trends, signaling the value trap narrative is prevailing.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nike's 12-month outlook, with a consensus price target around $55.41 and implied upside of +30.0% versus the current price.
Average Target
$55.41
17 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
17
covering this stock
Price Range
$34 - $55
Analyst target range
Analyst coverage is moderate with 17 firms providing estimates, and the institutional ratings show a mixed but cautious sentiment, with recent actions including a downgrade from Needham (Buy to Hold) and an upgrade from Barclays (Equal Weight to Overweight). The consensus recommendation is not explicitly provided in the data, but the pattern of recent ratings suggests a neutral to slightly bullish lean, though this is being tested by the severe price decline. The average revenue estimate for the period is $58.27 billion, with a range from $56.75 billion to $60.75 billion, indicating a relatively tight spread of about 7% and reflecting moderate uncertainty around the top-line recovery trajectory. The wide discrepancy between the stock's current price and its 52-week high, coupled with the recent wave of negative news, signals that analyst targets are likely in a state of significant downward revision, and the high target likely assumes a successful multi-year turnaround with margin expansion, while the low target prices in a prolonged period of market share loss and China weakness.
Bulls vs Bears: NKE Investment Factors
The evidence currently favors the bear case, as concrete deterioration in fundamentals (flat revenue, collapsing margins) outweighs the potential value offered by a deeply oversold technical setup. The most critical tension in the NKE investment debate is the timeline and viability of its corporate turnaround. Bulls argue the brand's enduring strength and clean balance sheet provide a multi-year runway for recovery, with current prices offering a historic margin of safety. Bears counter that deteriorating fundamentals, especially in China, and a still-rich valuation suggest the stock is a value trap, with earnings estimates likely to fall further before any sustainable rebound. The resolution of this tension hinges on concrete signs of sequential margin stabilization and a halt to market share losses in upcoming quarters.
Bullish
- Deeply Oversold at 52-Week Low: The stock is trading at $42.62, a mere 0.6% above its 52-week low of $42.36, following a 35.35% decline over the past three months. This extreme positioning suggests capitulation and could represent a technical bottom, offering a high-potential entry point for a long-term turnaround bet.
- Strong Balance Sheet & Liquidity: The company maintains a robust current ratio of 2.21 and a manageable debt-to-equity ratio of 0.83. This financial fortress provides Nike with the operational flexibility to navigate its turnaround without a liquidity crisis, supporting multi-year recovery efforts.
- Valuation at Historical Low End: The trailing P/E of 27.95x is near the lower end of its recent historical range, which has included multiples above 44x. This significant compression indicates the market has priced in substantial pessimism, reducing valuation risk and setting a lower bar for positive surprises.
- Respectable Return on Equity: Despite recent profit pressure, Nike's Return on Equity (ROE) stands at 24.36%. This indicates the brand's underlying power to generate profits from shareholder capital remains intact, providing a foundation for recovery if operational execution improves.
Bearish
- Severe Profitability Deterioration: Q3 net income collapsed to $520 million from $792 million in Q2, with net margin plunging to 4.61% from 6.37%. This sharp sequential decline in profitability, coupled with gross margin compression to 40.16%, signals deep operational challenges that undermine the investment thesis.
- Stalled Revenue & China Headwinds: Q3 revenue growth was essentially flat at 0.09% YoY and declined sequentially from $12.43B to $11.28B. News highlights a forecasted 20% sales decline in China, a critical market, indicating the core growth engine has stalled with no near-term catalyst for reacceleration.
- Elevated Valuation Despite Weak Fundamentals: A trailing P/E of 27.95x and forward P/E of 22.10x remain elevated for a company with stagnating growth and declining margins. This premium multiple leaves the stock vulnerable to further compression if earnings forecasts are cut, posing significant downside risk.
- Catastrophic Momentum & High Volatility: The stock is down 21.65% over the past year and 23.48% in the past month, severely underperforming the SPY by 23.94% over one month. With a beta of 1.319, this high volatility has amplified losses and reflects a complete breakdown in investor confidence, making a near-term recovery unlikely.
NKE Technical Analysis
The prevailing price trend is a severe and sustained downtrend, with the stock down 21.65% over the past year and trading at a mere 0.6% above its 52-week low of $42.36, positioning it at the absolute bottom of its 52-week range ($42.36 - $80.17). This extreme positioning suggests the stock is deeply oversold, but it also reflects a complete breakdown in market confidence, with the price action signaling capitulation rather than a clear value opportunity. Recent momentum has been devastatingly negative, with the stock plummeting 23.48% over the past month and 35.35% over the past three months, dramatically accelerating the longer-term downtrend; this divergence from the broader market is stark, as evidenced by a relative strength of -23.94% versus the SPY over one month. Key technical support is firmly established at the 52-week low of $42.36, while resistance is far above at the 52-week high of $80.17; a sustained breakdown below $42.36 would signal a new phase of weakness with no established technical floor, whereas any recovery would need to overcome a massive overhead supply zone. The stock's beta of 1.319 indicates it is approximately 32% more volatile than the market, which has amplified downside moves during this sell-off and underscores the heightened risk for position sizing.
Beta
1.32
1.32x market volatility
Max Drawdown
-46.2%
Largest decline past year
52-Week Range
$42-$80
Price range past year
Annual Return
-21.7%
Cumulative gain past year
| Period | NKE Return | S&P 500 |
|---|---|---|
| 1m | -23.5% | +2.6% |
| 3m | -35.3% | -2.3% |
| 6m | -34.7% | +2.6% |
| 1y | -21.7% | +27.3% |
| ytd | -32.6% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NKE Fundamental Analysis
Revenue growth has stalled and turned negative on a sequential basis, with the most recent Q3 FY2026 revenue of $11.28 billion representing a mere 0.09% year-over-year increase and a significant decline from the $12.43 billion reported in Q2; segment data shows Footwear ($7.91B) remains the core driver, but overall growth momentum has clearly decelerated. Profitability has deteriorated sharply, with Q3 net income of $520 million and a net margin of 4.61%, down substantially from the $792 million and 6.37% net margin in Q2; gross margin of 40.16% in Q3 also compressed from 40.60% in the prior quarter, indicating ongoing pricing and cost pressures. The balance sheet remains relatively healthy with a strong current ratio of 2.21 and a manageable debt-to-equity ratio of 0.83, but cash flow generation has weakened, with trailing twelve-month free cash flow of $2.48 billion; the Return on Equity of 24.36% remains respectable but is likely under pressure from declining net income, raising questions about the sustainability of returns on capital.
Quarterly Revenue
$11.3B
2026-02
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.40%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NKE Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Nike's trailing PE ratio stands at 27.95x, while its forward PE is 22.10x, indicating the market is pricing in an expectation of earnings recovery, as the forward multiple implies a 21% discount to the trailing figure. Compared to sector averages (data not available in the provided set for a direct comparison), the trailing PE of 27.95x appears elevated for a company with stagnating growth, suggesting the market may still be assigning a premium for the brand strength despite fundamental challenges. Historically, the current trailing PE of 27.95x is below the stock's own historical range seen in recent quarters, which has included figures above 44x (Q3 FY2026) and as low as 24x (Q4 FY2024); trading near the lower end of its own historical band suggests the market has already priced in significant pessimism, but it does not preclude further multiple compression if fundamentals continue to weaken.
PE
27.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 24x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute, centered on severe margin pressure and earnings volatility. Q3 net income fell 34% sequentially, and the net margin of 4.61% is less than half the level from a year ago. Free cash flow, while positive at $2.48B TTM, is under pressure from declining profitability. The company faces significant revenue concentration risk, with China representing a major growth market now forecast for a sharp decline, and footwear (70% of Q3 sales) driving the majority of revenue, leaving it exposed to category-specific shifts.
Market & Competitive Risks are heightened by valuation compression and competitive disruption. Trading at a forward P/E of 22.1x, NKE carries a growth premium despite showing no growth, making it highly sensitive to earnings misses. Competitors like On Holdings are cited as taking market share. The stock's beta of 1.319 means it is 32% more volatile than the market, amplifying downside during sector rotations away from challenged consumer discretionary names, as evidenced by its -51% relative strength versus the SPY over one year.
Worst-Case Scenario involves a failed turnaround where China weakness persists, margins continue to compress, and market share erosion accelerates. This could trigger a wave of analyst downgrades and multiple compression towards the stock's historical low P/E of ~24x. The realistic downside could see the stock re-test and break its 52-week low of $42.36, potentially falling another 20-30% into the mid-$30s range if sentiment completely sours, representing a loss of roughly 35% from the current price of $42.62.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Continued margin compression, as seen in the Q3 net margin drop to 4.61%, and prolonged weakness in the critical China market. 2) Valuation Risk: A forward P/E of 22.1x leaves the stock vulnerable to multiple compression if earnings estimates are cut. 3) Competitive Risk: Loss of market share to agile competitors like On Holdings, as noted in recent news. 4) Market Risk: High beta of 1.319 means the stock will likely fall more than the market in a downturn, amplifying losses.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees a slow grind towards a $50-$60 range as the company stabilizes. The Bull Case (20%) could see a rally to $65-$75 on successful turnaround signs. The Bear Case (20%) risks a fall to $35-$42 if fundamentals worsen. The most likely outcome is the base case, predicated on the assumption that Nike's powerful brand and balance sheet prevent a total collapse, but that a return to robust growth will take multiple years. The average analyst revenue estimate of $58.27B supports this view of slow, single-digit growth.
NKE is arguably overvalued relative to its current near-zero growth and declining profitability, but potentially undervalued relative to its long-term brand power if a recovery occurs. The trailing P/E of 27.95x is high for a company with 0.09% YoY revenue growth. However, this multiple is at the low end of its own historical range, suggesting the market has already priced in significant bad news. The valuation implies the market is still paying a premium for the Nike brand, expecting a future earnings recovery that is not yet visible in the financials.
NKE is a high-risk, high-potential-reward turnaround bet, not a straightforward 'good buy.' For patient, long-term investors with high risk tolerance, the current price near 52-week lows could offer an attractive entry point if the multi-year recovery materializes. However, with flat revenue, collapsing margins, and a forward P/E of 22.1x, significant near-term downside remains if execution falters. It is a good buy only for those who believe in the brand's long-term resilience and are prepared to hold through potential further volatility, not for those seeking stable growth or a quick trade.
NKE is strictly a long-term investment with a minimum suggested holding period of 3-5 years. The company is in the midst of a multi-year turnaround with no near-term catalysts for a sustained rally, making it a poor candidate for short-term trading. Its high beta of 1.319 induces excessive volatility for traders, and it does not pay a meaningful dividend (yield 2.56%) for income seekers. Only investors with a long time horizon can realistically wait for the operational recovery needed to justify the current valuation and realize the potential upside from today's depressed prices.